Decoding Damage: GPR35-KLF5 Signaling and Epithelial Repair in DSS-Induced Colitis

Study Background and Research Question

Ulcerative colitis (UC) is a chronic inflammatory bowel disease marked by cyclical damage and repair of the colonic mucosa. Central to its pathology is the disruption of the intestinal epithelial barrier, which not only initiates inflammation but also perpetuates tissue injury if not effectively repaired. Although the role of intestinal epithelial cells (IECs) in mucosal defense and regeneration is well-established, the molecular logic by which IECs sense and decode damage cues to activate repair programs remained undefined. Addressing this gap, the recent study by Xie et al. (Cell Death and Disease, 2026) investigates how IECs interpret metabolic signals of mucosal damage and orchestrate regeneration, with direct relevance to ulcerative colitis research and the optimization of mouse models using dextran sulfate sodium salt (DSS).

Key Innovation from the Reference Study

The central innovation of this work lies in the identification of a metabolic gatekeeping system that links tryptophan catabolism to epithelial repair. Specifically, the study demonstrates that G protein-coupled receptor 35 (GPR35) acts as a sensor for kynurenic acid (KA)—a key tryptophan metabolite generated via the tryptophan-kynurenine pathway. Through a unique “sandwich” structural binding mode, GPR35 detects fluctuations in KA levels, which are indicative of mucosal barrier disruption. This sensing event is then transduced through a regulatory circuit involving the transcription factor Kruppel-like factor 5 (KLF5), culminating in the activation of the PI3K-AKT-mTOR pathway. This axis precisely governs IEC proliferation and migration, underpinning effective mucosal repair (reference study).

Methods and Experimental Design Insights

The study leveraged a chemically induced model of colitis in mice, employing DSS (MW 35000-45000) to reproducibly disrupt the colonic epithelial barrier and induce acute intestinal inflammation. DSS is a well-validated chemical inducer of experimental colitis, mirroring key features of human UC—including epithelial apoptosis, barrier loss, and robust inflammatory responses. The research combined in vivo DSS administration with genetic and pharmacological manipulation of the GPR35-KLF5 axis. This included the use of GPR35 knockout and conditional KLF5-deficient mice, as well as supplementation with pathway metabolites (kynurenine and kynurenic acid). The experimental approach integrated histological analysis, immunofluorescence, gene expression profiling, and signaling pathway interrogation to dissect cellular and molecular responses during injury and repair.

Protocol Parameters

• DSS administration: 2.5–5% (w/w) dextran sulfate sodium salt (MW 35000-45000) in drinking water for 5–7 days to induce acute colitis, followed by water-only recovery phases for repair assessment (internal protocol guideline).
• Tissue collection: Colonic segments harvested at defined timepoints post-DSS to evaluate damage and regeneration.
• Genetic models: GPR35 knockout and KLF5-floxed mice crossed with IEC-specific Cre drivers to pinpoint cell-intrinsic roles.
• Metabolite supplementation: Systemic or local administration of kynurenine or kynurenic acid to probe metabolic signal transduction.
• Signaling analysis: Western blot and immunostaining for PI3K-AKT-mTOR pathway activation and downstream effectors of epithelial proliferation/migration.

Core Findings and Why They Matter

The authors show that upon DSS-induced epithelial injury, the tryptophan-KYN-KA metabolic axis is perturbed, leading to changes in KA availability at the mucosal interface. GPR35, highly expressed in IECs, detects these KA fluctuations with high specificity. Activation of GPR35 triggers a transcriptional response mediated by KLF5, which in turn mobilizes the PI3K-AKT-mTOR cascade—well known for its role in cell survival, proliferation, and migration. Disruption of any component in this circuit (GPR35, KLF5, or downstream signaling) impairs the ability of IECs to repair damaged mucosa, resulting in prolonged inflammation and tissue pathology (reference).

This mechanistic insight is significant because it deciphers how IECs act as biosensors, translating metabolic stress into regenerative responses. The findings directly inform the interpretation and refinement of DSS-induced mouse models of inflammatory bowel disease, where precise modulation of epithelial repair is essential for modeling human UC pathogenesis and evaluating candidate therapies. Targeting components of the GPR35-KLF5 circuit may offer new strategy for enhancing mucosal healing in UC.

Comparison with Existing Internal Articles

Recent internal resources have addressed both protocol optimization and mechanistic underpinnings of DSS-induced colitis models. For example, "Dextran Sulfate Sodium Salt: Precision in IBD Mouse Models" provides a detailed workflow for DSS administration, with troubleshooting strategies grounded in emerging knowledge of epithelial signaling. The reference study by Xie et al. advances this framework by offering a direct molecular explanation—specifically, the GPR35-KLF5 pathway—for how the colonic epithelium detects and responds to DSS-induced injury. Similarly, "GPR35-KLF5 Circuitry in Epithelial Repair: Insights from DSS Models" contextualizes the role of tryptophan metabolism and GPR35 signaling in mucosal healing, aligning closely with the current findings and reinforcing their translational value. These resources collectively support a more mechanistically informed approach to IBD modeling and epithelial repair studies using DSS.

Limitations and Transferability

While the study provides compelling evidence for GPR35-KLF5-mediated repair in mouse models, several considerations are warranted. First, the reliance on DSS as a chemical inducer of colitis, while clinically relevant, may not capture all aspects of human UC pathogenesis, including the full spectrum of immune and microbiota interactions. Second, the translation of these findings to human disease requires careful validation, as GPR35 expression and tryptophan metabolic flux may differ between species or disease states. Moreover, off-target effects of genetic manipulations and metabolic supplementation should be accounted for in follow-up studies.

Despite these caveats, the delineated circuitry offers a robust framework for dissecting epithelial repair and for refining the design of preclinical models. Researchers should consider integrating metabolic and transcriptional monitoring into DSS-based protocols to better capture the dynamics of mucosal healing.

Research Support Resources

For investigators aiming to model intestinal inflammation and epithelial repair, Dextran sulfate sodium salt (MW 35000-45000) (SKU B8205) remains a standard chemical tool, enabling reliable induction of colonic damage in mouse models. Its well-characterized mechanism—inducing epithelial apoptosis and barrier loss—makes it particularly suited for studies of epithelial regeneration and signaling, such as those involving the GPR35-KLF5 axis. Detailed information on solubility, storage, and administration protocols can be found on the supplier’s site, supporting reproducibility in experimental design. Investigators are encouraged to consult recent mechanistic and workflow articles to further optimize DSS-based models for their specific research aims.